Episode 54
Biotech Hangout
00:00
Regeneron and Depixant for COPD: Positive Data for Reduction of Exacerbations and Improvement of FEV1 and Symptoms
There's a lot more upside to be seen if these do work in IBD. Next up for Regeneron is going to be the Haidos Ileopidufa date at the end of June. We'll see if they have a presence at Asco before that, but it'll kind of be the next big update from them.
Transcript
Play full episode
